Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Drug Interaction Study Between YZJ-1139 and Escitalopram Oxalate
NCT06680531Phase 1Completed
- Sponsor
- Shanghai Haiyan Pharmaceutical Technology Co., Ltd.
- Start
- Aug 2024
- Primary completion
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of fazamorexant in Insomnia (2 arms), sponsored by Shanghai Haiyan Pharmaceutical Technology Co., Ltd. Primary endpoints: Saccade eye movement test, Body swing test and 11 more. Started Aug 2024; status: completed.
02
Drugs
fazamorexant
03
Conditions
Insomnia
Beyond the preview
Go deeper on NCT06680531.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06680531.